Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL7AP65 is a processed pseudogene of the ribosomal protein L7a gene, present in the human genome but does not encode a functional protein[4][11]. It shares sequence similarity with the protein-coding gene RPL7A, which encodes a structural component of the 60S ribosomal subunit, involved in protein synthesis[1][3]. As a pseudogene, RPL7AP65 does not participate in ribosome function, has no known biological activity, and is not involved in any diseases or drug interactions. The nomenclature reflects its origin as the 65th identified pseudogene of RPL7A in human genomic analysis[9][11].
None (not targeted by drugs; no known mechanism of action)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 65 (RPL7AP65).